Dr David Huggins received his degree in Chemistry from the University of Oxford. He remained there to earn his D.Phil. under the supervision of Professor Grahame Richards in the fields of molecular docking and algorithm design. He then spent two years as a postdoc with Professor Bruce Tidor at the Massachusetts Institute of Technology, where his research focused on molecular design. In 2007 he joined the University of Cambridge, where he worked at the interface of physics, chemistry, and biology as part of a team developing methods to tackle difficult drug targets. In January 2014 he was awarded an MRC New Investigator Research Grant to start a research group at the Cavendish Laboratory in Cambridge. In 2017 he moved to the Tri-Institutional Therapeutics Discovery Institute at Weill Cornell Medicine. His main areas of research are small-molecule design, drug target selection, and free energy calculations. This work is applied at the Tri-Institutional Therapeutics Discovery Institute, applying rational methods to design small-molecule inhibitors for diseases such as cancer, malaria, and tuberculosis.